Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dennie Fredrick"'
Autor:
Ryan J. Sullivan, James W. Mier, Keith T. Flaherty, A. John Iafrate, Michael B. Atkins, Dennie Fredrick, Anasuya Gunturi, F. Stephen Hodi, Virginia J. Seery, Ryan Merritt, Jennifer A. Wargo, Alexander Carlson, Rachel Cohen, David F. McDermott, Donald P. Lawrence, Alireza Sepehr, Laleh Montaser-Kouhsari, Aislyn P. Schalck, Anita Giobbie-Hurder, Elizabeth Buchbinder, David J. Panka
BRAF inhibitors (BRAFi) have led to clinical benefit in patients with melanoma. The development of a blood-based assay to detect and quantify BRAF levels in these patients has diagnostic, prognostic, and predictive capabilities that could guide treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4fef1a26720d8b3344d7e0a2a2f162
https://doi.org/10.1158/1535-7163.c.6536487
https://doi.org/10.1158/1535-7163.c.6536487
Autor:
Ryan J. Sullivan, James W. Mier, Keith T. Flaherty, A. John Iafrate, Michael B. Atkins, Dennie Fredrick, Anasuya Gunturi, F. Stephen Hodi, Virginia J. Seery, Ryan Merritt, Jennifer A. Wargo, Alexander Carlson, Rachel Cohen, David F. McDermott, Donald P. Lawrence, Alireza Sepehr, Laleh Montaser-Kouhsari, Aislyn P. Schalck, Anita Giobbie-Hurder, Elizabeth Buchbinder, David J. Panka
Supplemental Figure Legends from Clinical Utility of a Blood-Based BRAFV600E Mutation Assay in Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a0765140c494df0970dead7a9b648c5
https://doi.org/10.1158/1535-7163.22500519.v1
https://doi.org/10.1158/1535-7163.22500519.v1
Autor:
Ryan J. Sullivan, James W. Mier, Keith T. Flaherty, A. John Iafrate, Michael B. Atkins, Dennie Fredrick, Anasuya Gunturi, F. Stephen Hodi, Virginia J. Seery, Ryan Merritt, Jennifer A. Wargo, Alexander Carlson, Rachel Cohen, David F. McDermott, Donald P. Lawrence, Alireza Sepehr, Laleh Montaser-Kouhsari, Aislyn P. Schalck, Anita Giobbie-Hurder, Elizabeth Buchbinder, David J. Panka
BRAFV600E levels in patients with detectable BRAFV600E mutation in tissue who had peripheral blood cell isolation using CPT tubes vs Ficoll.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35cde1f5f1c23bee3093a7038029031c
https://doi.org/10.1158/1535-7163.22500525.v1
https://doi.org/10.1158/1535-7163.22500525.v1
Autor:
Aislyn Schalck, Virginia Seery, Anita Giobbie-Hurder, Anasuya Gunturi, Ryan M. Merritt, Alireza Sepehr, David F. McDermott, James W. Mier, Ryan J. Sullivan, Donald P. Lawrence, Elizabeth I. Buchbinder, Keith T. Flaherty, A. John Iafrate, F. Stephen Hodi, Dennie Fredrick, Jennifer A. Wargo, Laleh Montaser-Kouhsari, Michael B. Atkins, Alexander Carlson, David J. Panka, Rachel Cohen
Publikováno v:
Molecular cancer therapeutics. 13(12)
BRAF inhibitors (BRAFi) have led to clinical benefit in patients with melanoma. The development of a blood-based assay to detect and quantify BRAF levels in these patients has diagnostic, prognostic, and predictive capabilities that could guide treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0751eff848af4d63a1761855f201b921
https://pubmed.ncbi.nlm.nih.gov/25319388
https://pubmed.ncbi.nlm.nih.gov/25319388
